Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

被引:300
|
作者
Altamura, Sandro [1 ]
Muckenthaler, Martina U. [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Pediat Oncol Haematol & Immunol, Mol Med Partnership Unit, D-69120 Heidelberg, Germany
关键词
Alzheimer's disease; atherosclerosis; diseases of aging; iron; iron homeostasis; mouse model; Parkinson's disease; reactive oxygen species; CORONARY-ARTERY-DISEASE; EASTERN FINNISH MEN; RECESSIVE JUVENILE PARKINSONISM; HEMOCHROMATOSIS GENE-MUTATIONS; EARLY EMBRYONIC LETHALITY; LOW-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDES; TRANSFERRIN C2 ALLELE; SMOOTH-MUSCLE CELLS;
D O I
10.3233/JAD-2009-1010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
引用
收藏
页码:879 / 895
页数:17
相关论文
共 50 条
  • [1] Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease
    Brewer, George J.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 232 (02) : 323 - 335
  • [2] Iron in Alzheimer's disease and Parkinson's disease
    Bush, A.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 5 - 5
  • [3] Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
    Belaidi, Abdel A.
    Bush, Ashley I.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 179 - 197
  • [4] Understanding Verbal Fluency in Healthy Aging, Alzheimer's Disease, and Parkinson's Disease
    McDowd, Joan
    Hoffman, Lesa
    Rozek, Ellen
    Lyons, Kelly E.
    Pahwa, Rajesh
    Burns, Jeffrey
    Kemper, Susan
    [J]. NEUROPSYCHOLOGY, 2011, 25 (02) : 210 - 225
  • [5] Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
    Wlodarek, Dariusz
    [J]. NUTRIENTS, 2019, 11 (01):
  • [6] Tackling neurodegenerative diseases: animal models of Alzheimer’s disease and Parkinson’s disease
    Ahmed A. Raslan
    Yun Kee
    [J]. Genes & Genomics, 2013, 35 : 425 - 440
  • [7] Tackling neurodegenerative diseases: animal models of Alzheimer's disease and Parkinson's disease
    Raslan, Ahmed A.
    Kee, Yun
    [J]. GENES & GENOMICS, 2013, 35 (04) : 425 - 440
  • [8] Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies
    Kristinsson, Jakob
    Snaedal, Jon
    Torsdottir, Gudlaug
    Johannesson, Torkell
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 515 - 521
  • [9] Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow, Russell H.
    [J]. NEUROBIOLOGY OF AGING, 2007, 28 (10) : 1465 - 1480
  • [10] Altered brain iron depositions from aging to Parkinson's disease and Alzheimer's disease: A quantitative susceptibility mapping study
    Guan, Xiaojun
    Zhou, Cheng
    Guo, Tao
    Wu, Jingjing
    Zeng, Qingze
    Li, Kaicheng
    Luo, Xiao
    Bai, Xueqin
    Wu, Haoting
    Gao, Ting
    Gu, Luyan
    Liu, Xiaocao
    Cao, Zhengye
    Wen, Jiaqi
    Chen, Jingwen
    Wei, Hongjiang
    Zhang, Yuyao
    Liu, Chunlei
    Song, Zhe
    Yan, Yaping
    Yan, Jiali
    Zhang, Baorong
    Xu, Xiaojun
    Zhang, Minming
    [J]. NEUROIMAGE, 2022, 264